Mechanism of SGLT2 Inhibition in the Kidney

Abroad (travel likely)RecruitingPHASE4

Conditions

Type 2 Diabetes · Diabetic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Chrysta C Lienczewski, BS) · boridley@umich.edu · 734-615-5021
Contact: Principal Investigator (Markus Bitzer, MD)

Study leads

Markus Bitzer, MD
Principal Investigator
Professor of Internal Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Chronic Kidney Disease (Stages 4 and 5) · Kidney Disease · Type 2 Diabetes

Abroad (travel likely)Recruiting

Phoenix, United States

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Type 2 Diabetes Mellitus · Diabetic Kidney Disease · Adolescent Obesity

Abroad (travel likely)Recruiting

Aurora, United States · Seattle, United States

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Mesa, United States

Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure

Hypertension · Hypertension Complicated With Type 2 Diabetes

Abroad (travel likely)Recruiting

Baltimore, United States · Baltimore, United States